Clinical Trial

Blinatumomab Combined With Low-dose DLI as Maintenance Therapy After Transplantation for B-ALL

Name: Blinatumomab Combined With Low-dose DLI as Maintenance Therapy After Transplantation for B-ALL — clinical trial record (NCT07677878)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This prospective study will be conducted in high-risk B-ALL patients post-allo-HSCT. We propose to investigate the safety and therapeutic efficacy of blinatumomab plus low-dose DLI maintenance therapy, with the ultimate goal of enhancing long-term survival outcomes.

Trial Details

NCT Number	NCT07677878
Lead Sponsor	Liping Dou
Conditions	ALL (Acute B-Lymphoblastic Leukemia)
Enrollment	60 participants
Start Date	2024-12-01
Primary Completion	2028-11-30 (estimated)
Study Completion	2028-12-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-01